ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: 2159
    Pachymeningitis in Rheumatic Disease
  • Abstract Number: 2467
    Pain and Anxiety Are Independent Factors Associated to Sleep Impairment in Psoriatic Arthritis: A Multicentric Study in 14 Countries
  • Abstract Number: 2604
    Pain Chronification and the Important Role of Non-disease Specific Symptoms in Patients with Systemic Sclerosis
  • Abstract Number: 2845
    Pain Patterns in Idiopathic Inflammatory Myopathy (IIM): Associations with Disease Activity Measures (Muscle Enzymes, Manual Muscle Testing 8), Patient-Reported Quality of Life (HAQ) and Pain Scales (Widespread Pain Index (WPI), Symptom Severity Index (SSI) and Visual Analogue Scale)
  • Abstract Number: 628
    Pain Perception and Opiate Use Among Patients with Inflammatory Arthritis
  • Abstract Number: 153
    Palliative Care Curriculum in Rheumatology: Teaching Serious Illness Conversations
  • Abstract Number: 301
    PANLAR Ultrasound Study Group Recommendations for the Use of Imaging in the Management of Patients with Gout
  • Abstract Number: 3
    Pannexin-1 KO Mice Are Unresponsive to Tenofovir Induced Bone Loss
  • Abstract Number: 1053
    Parallel Analysis of Systemic Sclerosis and Keloidal Morphea Skin Biopsies Delineates the Hallmark Profibrotic Gene Expression Profile for Scleroderma in Vivo
  • Abstract Number: 2842
    Paraoxonase 1 Activity Is Abnormal in Patients with Idiopathic Inflammatory Myopathies and Associates with Poor Disease Control
  • Abstract Number: 2241
    Parent Perspectives on Addressing Emotional Health for Youth with Juvenile Myositis: A Qualitative Focus Group Study
  • Abstract Number: 1921
    Parent-Reported Medication Side-Effects and Their Impact on Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
  • Abstract Number: 2224
    Parkinson’s Disease and Risk of Fractures : A Meta Analysis of Cohort Studies
  • Abstract Number: 274
    Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis
  • Abstract Number: 1462
    Pathogenesis of Vaginal Dryness in Primary Sjögren’s Syndrome: A Histopathological Case-control Study
  • Abstract Number: 2257
    Patient and Clinical Characteristics Associated with Increased Willingness to Adopt RA Treatment After an Educational Intervention: An Analysis of the Confident Treatment Decisions for Living with Rheumatoid Arthritis (CONTROL-RA) Trial
  • Abstract Number: 2256
    Patient Beliefs and Perceptions of Methotrexate for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
  • Abstract Number: 2388
    Patient Characteristics Associated with Long Term Glucocorticoid Use in a Commercially Insured Incident RA Cohort
  • Abstract Number: 1380
    Patient Characteristics, Treatment Patterns, and Treatment Persistency in Biologic DMARD-Experienced Rheumatoid Arthritis Patients in a US RA Registry
  • Abstract Number: 1350
    Patient Disease Trajectories in Baricitinib-2 Mg-Treated Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs
  • Abstract Number: 2247
    Patient Factors Associated with Willingness to Change Rheumatoid Arthritis Medications
  • Abstract Number: 2539
    Patient Perception of Benefit and Risks Associated with Hydroxychloroquine Use in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 1196
    Patient Preference for an Electronic MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/ Routine Assessment of Patient Index Data), Which Gives Similar Results Compared to a Paper Version
  • Abstract Number: 2766
    Patient Preferences for Attributes of Treatments for Chronic Pain Associated with Osteoarthritis Pain and Chronic Low Back Pain That Differentiate Nerve-Growth Factor Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Opioids in the United States: A Discrete-Choice Experiment
  • Abstract Number: 2151
    Patient Reported Outcomes and Factors Predicting Clinical Disease Activity in Patients with Immune-Checkpoint Inhibitor Inflammatory Arthritis
  • Abstract Number: 423
    Patient Reported Outcomes over 2 Years in Psoriatic Arthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Routine Care – Was PRO Remission Achieved? Results from the EuroSpA Collaboration
  • Abstract Number: 1083
    Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice – Is PRO Remission Achieved? Results from the EuroSpA Collaboration
  • Abstract Number: 1209
    Patient-reported Outcome Measures in Systemic Lupus Erythematosus: Use in Clinical Practice – Preliminary Results from the Integrate Project
  • Abstract Number: 836
    Patient-Reported Outcomes from a Randomised, Open-Label, Parallel-Group Study Evaluating Ixekizumab versus Adalimumab in Patients with PsA Who Are Biologic DMARD Naïve: 24-Week Results
  • Abstract Number: 1423
    Patient-Reported Outcomes of Abatacept in Combination with MTX in Early, MTX-Naïve, ACPA Positive Patients with RA: 1-Year Results from a Phase IIIb Study
  • Abstract Number: 1375
    Patient-Reported Outcomes of Upadacitinib versus Adalimumab Use in Patients with Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate: 26-Week Analysis of a Phase 3 Study
  • Abstract Number: 1314
    Patient-Specific Reference Values for Objective Physical Function Tests: Cross-Sectional Analysis Using Data from the Osteoarthritis Initiative
  • Abstract Number: 1842
    Patients and Relatives Coping with Inflammatory Arthritis: Impact of Communication, Social Support and Relatives Burden on Patients Perceived Health
  • Abstract Number: 648
    Patients of African Descent Score Higher on Quality of Life Indices Despite Their Known Disease Severity
  • Abstract Number: 680
    Patients Who Do Not Fulfill the 2018 EULAR/ACR Criteria for Systemic Lupus Erythematosus Accrue Less Damage: Data from a Multicenter, Multiethnic US Cohort
  • Abstract Number: 1286
    Patients with Anti-tRNA Synthetase Syndrome Are More Likely to Present to Pulmonary Clinic and Have a Higher Prevalence and Severity of Lung Disease Than Patients with Other Types of Myositis or Systemic Sclerosis
  • Abstract Number: 2212
    Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA
  • Abstract Number: 230
    Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study
  • Abstract Number: 2313
    Patients with Rheumatoid Arthritis Have a Higher Risk of Bipolar Disorder: A Systematic Review and Meta-analysis
  • Abstract Number: 2702
    Patients’ and Parents’ Perception of Disease and Its Impact on Life in Juvenile Idiopathic Arthritis: Results from Multinational Virtual Focus Groups by the OMERACT JIA Working Group
  • Abstract Number: 2260
    Patients’ Journeys Through Giant Cell Arteritis: A Qualitative Study
  • Abstract Number: 570
    Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up of Ankylosing Spondylitis (AS) Patients with a Rheumatologist-patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China
  • Abstract Number: 1252
    Pattern of Arthropathy in Patients with Cystic Fibrosis
  • Abstract Number: 347
    Patterns and Clinico-Radiological Correlates of Symptomatic Atlantoaxial Joint Involvement in Patients with Calcium Pyrophosphate Deposition Disease
  • Abstract Number: 2795
    Patterns of Ambulatory Health Care Utilization and Medication Adherence Among Transition-Age Youth with Systemic Lupus Erythematosus
  • Abstract Number: 2712
    Patterns of Etanercept Use in the Childhood Arthritis and Rheumatology Research Alliance Juvenile Idiopathic Arthritis Registry
  • Abstract Number: 1334
    Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 689
    Patterns of High Disease Activity Status and Outcomes in Systemic Lupus Erythematosus
  • Abstract Number: 1119
    Patterns of Medication Use for Patients with Sarcoidosis: Data from the ACR’s RISE Registry
  • Abstract Number: 348
    Patterns of Newer Gout Medication Use in a U.S. Electronic Health Record-Based Registry
  • Abstract Number: 1340
    Patterns of Sustained Remission and Subsequent DMARD Tapering in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort
  • Abstract Number: 1009
    PDE4 Inhibition Could Improve Endothelial and Adipose Tissue Dysfunction Associated with Psoriatic Arthritis, Key Processes in Cardiovascular Disease
  • Abstract Number: 1750
    Pediatric Sjögren Syndrome: A Single-Center Experience
  • Abstract Number: 1249
    Pelvic Congestion Syndrome, an Uncommon Cause of Osteoarticular Pain
  • Abstract Number: 2813
    Pentameric, but Not Monomeric C-reactive Protein, Limits the SnRNP-immune Complex Triggered Type I Interferon Response: Implications for Lupus Pathogenesis
  • Abstract Number: 1720
    Pentoxifylline Gel for Oral Ulcers in Patients with Behçet’s Syndrome
  • Abstract Number: 1824
    Perceived Stress Independently Associates with Worse Type 2 Symptoms in Systemic Lupus Erythematosus
  • Abstract Number: 171
    Performance of 2010 ACR/EULAR and 1987 ACR Criteria for Classification of Rheumatoid Arthritis in a Population-based Incidence Cohort, 2010-2014
  • Abstract Number: 2640
    Performance of Berden’s Classification and ANCA Renal Risk Score for the Prediction of End-Stage Renal Disease in ANCA-associated Vasculitis
  • Abstract Number: 1373
    Performance of CQR5 vs CQR19 in the Evaluation of Adherence to Tofacitinib in Daily Clinical Practice
  • Abstract Number: 401
    Performance of EULAR/ACR Classification Criteria for Idiopathic Inflammatory Myopathies in a Real-life Cohort of Adult Patients
  • Abstract Number: 677
    Performance of Montreal Cognitive Assessment (MoCA) in Screening for Cognitive Impairment in Patients with Lupus Compared to the Neuropsychological Battery
  • Abstract Number: 657
    Performance of the “Do You Know What I Mean” Questionnaire in the Assessment of Disease Knowledge in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 593
    Performance of the ASAS Classification Criteria Presenting with Undiagnosed Back Pain: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort
  • Abstract Number: 678
    Performance of the EULAR/ACR 2019 Classification Criteria for Systemic Lupus Erythematosus in Men, Diverse Ethnicities, and Early Disease
  • Abstract Number: 400
    Performance of the European League Against Rheumatism/American College of Rheumatology Idiopathic Inflammatory Myopathies Classification Criteria in a Myositis Cohort from Argentina
  • Abstract Number: 413
    Performance of the Patient Reported Outcomes Measurement Information System 29-item Profile in Comparison to the Clinical Disease Activity Index (CDAI) and Routine Assessment of Patient Index Data 3 (RAPID3) in an Australian Rheumatoid Arthritis Cohort
  • Abstract Number: 1206
    Performance of the Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) Item Profile in a Cohort of Australians with RA, OA and Other Inflammatory Arthritic Conditions
  • Abstract Number: 650
    Performance of the Proposed American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Lupus Erythematosus in Korean Patients
  • Abstract Number: 1803
    Performance of the RABBIT Infection Score in a Prospective Multicenter Cohort of Rheumatoid Arthritis Patients from Argentina
  • Abstract Number: 536
    PERFUSE: A French Prospective/Retrospective Non-interventional Cohort Study of Infliximab-naïve and Transitioned Patients Receiving Infliximab Biosimilar SB2; An Interim Analysis
  • Abstract Number: 911
    Perfusion in Bone Marrow Lesions Assessed on Dynamic Contrast-enhanced MRI and Its Association with Pain in Knee Osteoarthritis: A Cross-sectional Study
  • Abstract Number: 372
    Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience
  • Abstract Number: 1175
    Periarticular Inflammation and Bone Marrow Oedema Are Important in the Evaluation of Enthesitis on MRI in Patients with Peripheral and Axial SpA
  • Abstract Number: 2007
    Periodontal Pockets as a Potential Source of Circulating TREM-1 and Its Ligand PGLYRP1 in Patients with Rheumatoid Arthritis
  • Abstract Number: 1805
    Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study
  • Abstract Number: 2161
    Perioperative Glucocorticoid Management in Patients with Rheumatologic Diseases Undergoing Elective Joint Surgeries
  • Abstract Number: 663
    Peripheral Blood Toll Like Receptor 7 Expression and Serum Interferon Lambda 1 Levels in Systemic Lupus Erythematosus and Their Relation to Disease Activity and Lupus Nephritis
  • Abstract Number: 617
    Peripheral Involvement Is Associated with Less Radiographic Spinal Progression in Patients with Early Axial Spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort
  • Abstract Number: 671
    Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
  • Abstract Number: 2870
    Persistence of B Cell-rich Synovitis Following Conventional Synthetic Disease Modifying Anti-Rheumatic Drug Treatment in Early Rheumatoid Arthritis Is Associated with Radiographic Progression Independently of Clinical Response
  • Abstract Number: 1396
    Persistence of Tocilizumab Therapy Among Patients with Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
  • Abstract Number: 1505
    Persistence with Etanercept in Patients with Ankylosing Spondylitis or Psoriatic Arthritis in Germany: A Real-World Analysis
  • Abstract Number: 1602
    Persistency in Platelet C4d and Thrombosis Risk Score Associate with Thrombosis in Systemic Lupus Erythematosus
  • Abstract Number: 451
    Persistent and Non-Articular Regional and Widespread Pain Are Common in Early Rheumatoid Arthritis, Impacting Remission Rates and Reflected in Patient Global Scores
  • Abstract Number: 1572
    Persistent Cognitive Impairment in Lupus Patients over 1 Year and Associated Factors
  • Abstract Number: 1728
    Persistent Disease Activity Is Associated with Avascular Necrosis Development in Juvenile Systemic Lupus Erythematosus
  • Abstract Number: 114
    Persistent Synovial Resident Memory T Cells Mediate Arthritis Flares
  • Abstract Number: 2278
    Perspectives About Contraception Among Reproductive-Aged Women with Rheumatic Diseases
  • Abstract Number: 2277
    Perspectives of Female Patients with Rheumatic Diseases Regarding Pregnancy Planning with Rheumatologists
  • Abstract Number: 2860
    Perturbation of the Human Gut Microbiome by Methotrexate Contributes to the Resolution of Inflammation and Autoimmune Disease
  • Abstract Number: 2671
    PET/CT Vascular Findings at Baseline and Six Months in Patients with Newly Diagnosed Giant Cell Arteritis
  • Abstract Number: 993
    pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Rheumatoid Arthritis
  • Abstract Number: 2058
    Pharmacoepidemiology of Gout Treatment in Office-based Outpatient Care from 2009- 2016
  • Abstract Number: 1694
    Pharmacogenetics and Pharmacodynamics of Response to Apremilast in a Phase 3 Clinical Study in Subjects with Active Behçet’s Disease
  • Abstract Number: 2565
    Pharmacokinetics and Exposure-response of Intravenous Belimumab in Children with Systemic Lupus Erythematosus
  • Abstract Number: 2668
    Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination with Prednisone Tapering in Patients with Giant Cell Arteritis: 3-Year Results from a Randomized Controlled Phase 3 Trial
  • Abstract Number: 2541
    Pharmacokinetics of Hydroxychloroquine in Systemic Lupus Erythematosus Patients with Renal Impairment
  • Abstract Number: 2580
    Pharmacotherapies Targeting Type 2 SLE Symptoms
  • Abstract Number: 1217
    Phase 2 Dose-ranging Study of SEL-212 in Symptomatic Gout Patients: Selection of Doses for Further Clinical Development
  • Abstract Number: 530
    Phase I Evaluation of the PDE4 Inhibitor LY2775240: Head to Head Comparison with Apremilast Using an Ex Vivo Pharmacodynamic Assay
  • Abstract Number: 48
    Phenotype-based Clustering Along with Analysis of Molecular Profile Might Help to Define Precise CV-risk Profiles in RA Patients
  • Abstract Number: 2259
    Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group
  • Abstract Number: 1845
    Physical Inactivity Is a Risk Factor for Incident Depression in Systemic Lupus Erythematosus
  • Abstract Number: 954
    Physical Therapy and Opioid Use in Knee Osteoarthritis
  • Abstract Number: 1128
    Physician-Patient Interaction and Medication Adherence in Lupus Nephritis
  • Abstract Number: 1061
    PI3K-Akt Pathway Plays a Crucial Role in Production of Collagen in Fli1 Deficient Condition and Its Inhibitor Has the Therapeutic Potential in Treating Fibrosis
  • Abstract Number: 1216
    Pilot, Randomized, Double-Blinded, Placebo Controlled Efficacy AndSafety Study of a Transdermal Alkalinizing and Pain Relieving Treatment ForAcute Gout Flare
  • Abstract Number: 2563
    PK/PD, Safety and Exploratory Efficacy of Subcutaneous Anifrolumab in SLE: A Phase-II Study in Interferon Type I High Patients with Active Skin Disease
  • Abstract Number: 1617
    Platelet Bound Complement Split Product (PC4d) May Be a Marker of Platelet Activation and Cardiovascular Events in Systemic Lupus Erythematosus
  • Abstract Number: 979
    Platelet Derived Growth Factor Receptor Alpha (PDGFRα) Blockade Inhibits Arthritis in Mice
  • Abstract Number: 2790
    Platelet Mediates Neutrophil Extracellular Traps Formation via TLR Signaling in ANCA-associated Vasculitis
  • Abstract Number: 1960
    Pleiotropy of Genetic Predisposition to Rheumatoid Arthritis Increases the Risk for Autoimmune Disease
  • Abstract Number: 1959
    Pleiotropy of Systemic Lupus Erythematosus (SLE) Risk Alleles: Association with Increased Risk for Type 1 Diabetes (T1D) Complications Through a PTPN22 Polymorphism
  • Abstract Number: 1471
    Polyautoimmunity and Major Organ Involvement Prevalence in Sjögren´s Syndrome: Thyroid, Liver, Lung and Kidney as Targets. a Single Center Cross Sectional Study
  • Abstract Number: 1945
    Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients
  • Abstract Number: 118
    Polymorphonuclear Neutrophils and Regulatory T Lymphocytes (Treg) Cooperate to Sustain Treg Activity but This Interaction Is Altered in Rheumatoid Arthritis Patients
  • Abstract Number: 759
    Polymyalgia Rheumatica Patients with and Without Elevated Baseline Acute Phase Reactants: Distinct Subgroups of Polymyalgia Rheumatica?
  • Abstract Number: 742
    Polymyalgia Rheumatica: New Therapeutic Strategy Based on Low Dose Metrotexate Plus Local Infiltration with Corticosteroids
  • Abstract Number: 761
    Polymyalgia Rheumatica: Winter Is Coming
  • Abstract Number: 2245
    Polymyositis (PM) and Dermatomyositis (DM) Symptom Flares and Associated Impact from the Patient Perspective
  • Abstract Number: 2566
    Polypharmacy and Potentially Inappropriate Medication Use in Young versus Older Adults with SLE
  • Abstract Number: 1329
    Pooled Safety Analyses from Phase 3 Studies of Filgotinib in Patients with Rheumatoid Arthritis
  • Abstract Number: 436
    Poor Concordance Between Remission Judged by Physicians and a Patient-Acceptable Symptom State in Psoriatic Arthritis
  • Abstract Number: 1569
    Poor Long-term Renal Outcome in Systemic Lupus Erythematosus Without Abnormal Urinalysis: A Possible Link with Silent Lupus Nephritis
  • Abstract Number: 1716
    Poor-Prognosis Factors of Systemic Vasculitides with Gastrointestinal Involvement: Data from a Large Retrospective Study
  • Abstract Number: 1343
    Pop a Pill or Give Myself a Shot? Patient Perspectives of Disease-modifying Anti-rheumatic Drug (DMARD) Choice for Rheumatoid Arthritis (RA)
  • Abstract Number: 2077
    Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia and the Fallacy of the Variance Explained
  • Abstract Number: 2549
    Population Pharmacokinetics of Atacicept in Systemic Lupus Erythematosus (SLE) – an Analysis of Three Clinical Trials
  • Abstract Number: 1463
    Positive Rate of Small Intestinal Bacterial Overgrowth Test (SIBO) Was Significant Correlations to Disease Activity of Primary Sjogren’s Syndrome (pSS)
  • Abstract Number: 1411
    Positivity of Anti-Ro/SSA Antibody Confer Poor Response and Persistence with Abatacept Therapy
  • Abstract Number: 2261
    Post Traumatic Stress Disorder in Patients with Rheumatoid Arthritis
  • Abstract Number: 2372
    Post-Approval Comparative Safety Study of Tofacitinib and Biologic DMARDs: Five‑Year Results from a US-based Rheumatoid Arthritis Registry
  • Abstract Number: 1346
    Post-Traumatic Stress Disorder, Depression, Anxiety and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis
  • Abstract Number: 73
    Potent Anti-neutrophil Properties of the Natural Compound 6-Gingerol in Models of Lupus and Antiphospholipid Syndrome
  • Abstract Number: 1774
    Potential Involvement of OX40 Expressing Tfh Cells on Regulation of Autoantibody Sialylation in Experimental and Rheumatoid Arthritis
  • Abstract Number: 649
    Potentially Reversible Associations with Fatigue in SLE Patients – Results from a Single-centre Study
  • Abstract Number: 1147
    Poverty and Systemic Lupus International Collaborating Clinics Damage Index (SDI) Are Significant Risk Factors for Hospitalization in SLE Patients
  • Abstract Number: 1198
    Practice Based Education Program to Increase Vaccination Rate in Patients on Immunotherapeutic Agents
  • Abstract Number: 368
    Practice Patterns in Bone Health and Vitamin D Management in Sarcoidosis: A Survey of Physicians Who Manage Sarcoidosis
  • Abstract Number: 1747
    Practice Variations in Treatment of Pediatric Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (AAV) with Renal Disease
  • Abstract Number: 1445
    Pre-Biologic Use of Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis in the United States
  • Abstract Number: 495
    Pre-Rheumatoid Arthritis Diagnosis Prevalence of Commercial CCP Antibody Positivity Increases over Time with Strong Agreement Between Commercial Assays and Positivity Is Predicative of Developing Rheumatoid Arthritis Within 3 Years
  • Abstract Number: 314
    Pre-treatment Screening for Hepatitis B and C Among Users of Biologics or New Synthetic Disease Modifying Drugs: An Analysis Using RISE Data
  • Abstract Number: 1983
    Preclinical Evaluation of Targeting TGF-beta Signaling and Senescence in ex Vivo Models of Human Knee and Spine Osteoarthritis
  • Abstract Number: 1084
    Predicting ASDAS Inactive Disease After 6 Months of TNFi Treatment in Bio-Naive Axial Spondyloarthritis Patients Treated in Clinical Practice – Results from the EuroSpA Collaboration
  • Abstract Number: 194
    Predicting Remission in Rheumatoid Arthritis: External Validation for Tocilizumab Monotherapy Using Corrona Real World Data
  • Abstract Number: 1519
    Predicting Response to Biologic Therapy in Patients with Axial Spondyloarthritis (axSpA)
  • Abstract Number: 2499
    Predicting Risk of Developing Psoriatic Arthritis (PsA) in Siblings of Patients with Psoriatic Arthritis
  • Abstract Number: 466
    Predicting Risk of Radiographic Progression for Patients with Rheumatoid Arthritis
  • Abstract Number: 1390
    Prediction of Clinical Response to Abatacept in Rheumatoid Arthritis Patients Through the Determination of Anti-Carbamylated Proteins Antibodies Levels
  • Abstract Number: 2390
    Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission
  • Abstract Number: 2335
    Prediction of Myocardial Fibrosis in Rheumatoid Arthritis Assessed by Cardiac Magnetic Resonance Imaging Using Artificial Neural Networks Models
  • Abstract Number: 1610
    Prediction of Organ Damage Accrual in Systemic Lupus Erythematosus Using a Frailty Index
  • Abstract Number: 2844
    Predictive Factors for Mortality in Anti-melanoma-associated Gene 5 Antibody-associated Interstitial Lung Disease
  • Abstract Number: 2912
    Predictive Factors for Treatment Related Mortality and Event-Free Survival After Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Results of a Long Term Follow-up Multi-centre Study
  • Abstract Number: 1300
    Predictor of Placebo Response in Hand Osteoarthritis: A Post Hoc Analysis of Two Randomized Controlled Trials
  • Abstract Number: 2625
    Predictors of Advanced Chronic Kidney Disease in Patients with ANCA Vasculitis and Renal Involvement
  • Abstract Number: 2491
    Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice– Results from the EuroSpA Collaboration
  • Abstract Number: 1715
    Predictors of Gastrointestinal and Renal Involvement in Adult IgA Vasculitis
  • Abstract Number: 2719
    Predictors of Health Care Transition Practices Among North American Pediatric Rheumatology Providers
  • Abstract Number: 1137
    Predictors of Health-Related Quality of Life in Patients with Musculoskeletal Diseases: A Longitudinal Analysis from an Electronic Health Record Database
  • Abstract Number: 2794
    Predictors of Incident and Worsening Lumbar Spine Degeneration: The Johnston County Osteoarthritis Project
  • Abstract Number: 766
    Predictors of Long-term Therapy with Glucocorticoid in Polymyalgia Rheumatica
  • Abstract Number: 1843
    Predictors of Mortality Among Black Women with Systemic Lupus Erythematosus: The Black Women’s Experiences Living with Lupus (BeWELL) Study
  • Abstract Number: 2650
    Predictors of Relapse in Giant Cell Arteritis: Data from an International Collaboration
  • Abstract Number: 651
    Predictors of Renal Damage in Systemic Lupus Erythematosus Patients from Latin America
  • Abstract Number: 2787
    Predictors of Renal Involvement in ANCA-Associated Vasculitis
  • Abstract Number: 1430
    Predictors of Response to Etanercept-Methotrexate Treatment: Post-hoc Analysis of a Randomized, Open-label Study in Latin American Patients with Rheumatoid Arthritis
  • Abstract Number: 785
    Predictors of Response to Tumour Necrosis Factor – α Inhibitors (TNFi) in Juvenile Idiopathic Arthritis (JIA): A Single-center Experience
  • Abstract Number: 1544
    Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry
  • Abstract Number: 1418
    Predictors of Response, Adverse Events and Treatment Retention in RA Patients Treated with Either Subcutaneous- or Intravenous- Golimumab in a Prospective, Observational Registry
  • Abstract Number: 2458
    Predictors of Structural Progression in Psoriatic Arthritis: Clinical versus Systemic Inflammation
  • Abstract Number: 934
    Predictors of Survival of Secukinumab Treatment in a Multicenter Cohort of 556 Spondylarthritis
  • Abstract Number: 2914
    Predictors to Develop Definite Systemic Sclerosis (SSc): Results from an International Multicentre Study on Very Early DiagnOsis of Systemic Sclerosis (VEDOSS)
  • Abstract Number: 2140
    Preexisting Autoimmune Disease and Rheumatic Immune-Related Adverse Events Associated with Cancer Immunotherapy: A Case Series from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
  • Abstract Number: 2268
    Preferences and Insights for Rheumatoid Arthritis Clinical Prevention Trial Participation
  • Abstract Number: 141
    Pregnancy in Antiphospholipid Syndrome: Outcomes and Risk Factors – Data from a Portuguese Multidisclinary Unit
  • Abstract Number: 2293
    Pregnancy in Patients with Systemic Lupus Erythematosus After Cyclophosphamide Therapy
  • Abstract Number: 2279
    Pregnancy in Rheumatoid Arthritis: Continue, Reduce or Stop TNF Inhibitors? A Prospective Observational Study
  • Abstract Number: 751
    Pregnancy Outcome in Patients with Takayasu Arteritis: The Results of Turkish Takayasu Study Group
  • Abstract Number: 2288
    Pregnancy Outcomes in Women Exposed to Golimumab
  • Abstract Number: 2775
    Pregnancy Rates and Outcomes in Early Axial Spondyloarthritis: Analysis of the DESIR Cohort
  • Abstract Number: 801
    Preliminary Analysis of Hearing Loss in a Neonatal-Onset Multisystem Inflammatory Disease (NOMID) Cohort Followed over a Mean of 10 Years: Normal Hearing at Baseline and Early Treatment with Anakinra Area Associated with Maintenance of Normal Hearing
  • Abstract Number: 1908
    Preliminary Identification of Arthritis-Associated Microbiota in Experimental Spondyloarthritis
  • Abstract Number: 390
    Preliminary Response to Janus Kinase (JAK) Inhibition with Baricitinib in Refractory Juvenile Dermatomyositis
  • Abstract Number: 2264
    Prescribing Exercise: Facilitators and Barriers to the Successful Implementation of Physical Activity Guidelines in Inflammatory Arthritis
  • Abstract Number: 760
    Prescribing Methotrexate in Polymyalgia Rheumatica: A Missed Opportunity?
  • Abstract Number: 2553
    Prescription Opioid Use and Osteoporotic Fractures in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
  • Abstract Number: 1579
    Presence of Antiphospholipid Antibodies in Patients with SLE and Venous Thromboembolic Events of African American and Caucasian Race
  • Abstract Number: 2002
    Presence of the MerTK Receptor on Human Synovial Tissue Macrophages Lowers Inflammatory Cytokine Production and Activation of the MerTK+CD206+ Subpopulation Limits the Inflammatory Response of Synovial Fibroblasts
  • Abstract Number: 2673
    Presentation and Management of Giant Cell Arteritis in a Real-World Setting (Artemis Study)
  • Abstract Number: 327
    Presentation Order Bias in Rheumatology Journals: A Content Analysis
  • Abstract Number: 2597
    Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis
  • Abstract Number: 1576
    Prevalence and Outcome of Thrombocytopenia in Systemic Lupus Erythematosus – Single Centre Cohort Analysis
  • Abstract Number: 384
    Prevalence and Predictors of Fibrosis in Rheumatological Patients on Therapy and Risk Factors for Chronic Liver Disease
  • Abstract Number: 2583
    Prevalence and Risk Factors of Herpes Zoster Reactivation in Patients with Biopsy Proven Lupus Nephritis Undergoing Immunosuppressive Therapies
  • Abstract Number: 2398
    Prevalence of Anxiety and Depression in a Cohort of Patients with Rheumatic Diseases on Biological Infusions
  • Abstract Number: 903
    Prevalence of Atopic Features in Classic Autoinflammatory Diseases
  • Abstract Number: 1120
    Prevalence of Burnout in Rheumatology Professionals
  • Abstract Number: 1589
    Prevalence of Cognitive Impairment in an Inception Lupus Cohort as Assessed by a Comprehensive Neuropsychological Battery
  • Abstract Number: 2087
    Prevalence of Corticosteroid Use in Incidental Vertebral or Hip Fractures
  • Abstract Number: 1103
    Prevalence of Diagnosed Systemic Lupus Erythematosus (SLE), Patient Healthcare Utilization and Characteristics by Major Health Insurance Types in the US
  • Abstract Number: 2475
    Prevalence of Disease Domain Presentations Among Patients with Psoriatic Arthritis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
  • Abstract Number: 296
    Prevalence of Elbow Arthritis in Patients with Rheumatoid Arthritis: A Prospective Ultrasound Study
  • Abstract Number: 410
    Prevalence of Malignancy in Myositis Patients with Anti-aminoacyl-tRNA Synthetase Antibodies: A Single Center Retrospective Study and Literature Review
  • Abstract Number: 1601
    Prevalence of Peripheral Neuropathy and Its Electrophysiological Types in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2163
    Prevalence of Postoperative Anemia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Undergoing Total Knee Arthroplasty: A Study of National Inpatient Sample 2010-2014
  • Abstract Number: 608
    Prevalence of Radiographic Entheseal Lesions at the Hip and Pelvic Region in Patients with Ankylosing Spondylitis versus Controls
  • Abstract Number: 181
    Prevalence of Renal Impairment in a US Rheumatoid Arthritis Population
  • Abstract Number: 1174
    Prevalence of Subclinical Sacroiliitis in Young Patients with Inflammatory Bowel Disease Revealed by Entero-MRI
  • Abstract Number: 1311
    Prevalence of Symptomatic Axial Osteoarthritis and Poliarticular Phenotypes in Spain: EPISER 2016 Study
  • Abstract Number: 2886
    Prevalence of Systemic Lupus Erythematosus in the United States: Preliminary Estimates from a Meta-Analysis of the Centers for Disease Control and Prevention Lupus Registries
  • Abstract Number: 2072
    Prevalence of Thyroid Dysfunction with Therapeutic Indication in Patients with Rheumatological Diseases
  • Abstract Number: 2306
    Prevalent and Incident Multimorbidity in Rheumatoid Arthritis: A Population-Based Cohort Study
  • Abstract Number: 1549
    Primary 1-Year Data of Ixekizumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Patients with Radiographic Axial Spondyloarthritis Including Data in Patients Rerandomized from Adalimumab to Ixekizumab
  • Abstract Number: 352
    Primary Hyperparathyroidism Is Associated with a Higher Level of Serum Uric Acid: A Systematic Review and Meta-analysis
  • Abstract Number: 1472
    Primary Sjögren’s Syndrome and Development of Another Connective Tissue Disease During Follow-up
  • Abstract Number: 454
    Principal Component Analysis Identifies Unique Sub-Populations in Rheumatoid Arthritis Using a Combination of Serological Biomarkers: A Cross Sectional Study
  • Abstract Number: 2149
    Principal Components Analysis as a Tool to Identify Lesional Skin Patterns in Cutaneous Lupus Erythematosus
  • Abstract Number: 703
    Prior Knowledge Feature Reduction Improves Performance in a Machine Learning Model of Systemic Lupus Erythematosus Flare Status Using Serum Proteomics
  • Abstract Number: 1085
    Probiotic Use and Psoriatic Arthritis Disease Activity
  • Abstract Number: 481
    Production of IL17A in Synovial Tissue Correlates with MRI RAMRIS Scores in ACPA Positive Early Rheumatoid Arthritis
  • Abstract Number: 1056
    Profibrotic Macrophage Activation in Systemic Sclerosis Is Dependent on the Mechanosensing MRTF-A Pathway
  • Abstract Number: 2301
    Profile of Renal Function in Patient Suffering from Rheumatoid Arthritis
  • Abstract Number: 2705
    Profiling Behavioral and Psychological Symptoms in Children with Spondyloarthritis and Polyarthritis
  • Abstract Number: 2558
    Profiling of Gene Expression, Immune Cell Subtypes, and Circulating Protein Biomarkers in Systemic Lupus Erythematosus Patients Treated with the Selective Immunoproteasome Inhibitor, KZR-616
  • Abstract Number: 2289
    Progesterone Decreases Gut Permeability Through Upregulating Occludin Expression in Primary Human Gut Tissues and Caco-2 Cells
  • Abstract Number: 465
    Prognostic Factors and Clinical Outcome Modifiers in Patients with Rheumatoid Arthritis: A Review
  • Abstract Number: 373
    Prognostic Factors and Long-term Outcomes in Cardiac Sarcoidosis
  • Abstract Number: 2326
    Prognostic Markers for Preclinical Cardiovascular Disease in Rheumatoid Arthritis and Correlation with Disease Activity
  • Abstract Number: 2587
    Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis
  • Abstract Number: 1583
    Prognostic Value of Urinary Biomarkers for the Developing of End Stage Renal Disease in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1624
    Progression and Factors Associated with Damage Accrual in a SLE Inception Cohort of Hispanic Patients
  • Abstract Number: 2823
    Progression to Inflammatory Arthritis After Screening Autoantibody Positive in a Non-Clinical Setting
  • Abstract Number: 300
    Proliferative Globular Synovitis, an Ultrasound Pattern Associated with Seropositive Rheumatoid Arthritis
  • Abstract Number: 2454
    PROMIS Profile29 Differentiates Active Disease from Treat-to-Target State in Psoriatic Arthritis
  • Abstract Number: 1040
    Proposition of a Novel Animal Model of Systemic Sclerosis Induced by Type V Collagen in C57BL/6 Mice Reproducing Fibrosis, Vasculopathy and Autoimmunity
  • Abstract Number: 2882
    Prospective Demonstration That Attainment of the Lupus Low Disease Activity State Is Associated with Improved Health Related Quality of Life
  • Abstract Number: 2567
    Prospective Evaluation of American Academy of Ophthalmology Low Dose Hydroxychloroquine Recommendation in Stable Lupus Nephritis with High-Risk Retinopathy: Lipid Profile and Flare Rates
  • Abstract Number: 596
    Prostaglandin Receptor EP4 Drives Pathogenic Th17 Cell Development in Ankylosing Spondylitis and Is a New Marker of Disease Activity
  • Abstract Number: 1973
    Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies
  • Abstract Number: 2405
    Protein Biomarkers Predicting the Response to IFX+MTX+LEF Treatment in Patients with Rheumatoid Arthritis
  • Abstract Number: 2004
    Protein Profiling and Network Enrichment Analysis in Individuals Before and After the Onset of Rheumatoid Arthritis
  • Abstract Number: 1055
    Proteomic and Transcriptomic Analysis of Human Eosinophilic Fasciitis Fibroblasts
  • Abstract Number: 2557
    Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics and Outcomes – Case Control Study
  • Abstract Number: 2825
    Provider Variability in Glucocorticoid Prescribing for Patients with Rheumatoid Arthritis and Impact on Chronic Glucocorticoid Use
  • Abstract Number: 1816
    Psoriasis Associated with Anti-Tumor Necrosis Factor-Alpha Therapies in Children with Inflammatory Bowel Disease, Juvenile Idiopathic Arthritis, and Chronic Noninfectious Osteomyelitis
  • Abstract Number: 2509
    Psoriasis Impact on Patient-Reported Outcomes in Psoriatic Arthritis in a Real-World Setting: Results from the APOPSIS Study
  • Abstract Number: 1086
    Psoriatic Arthritis – Epidemiology, Incidence Rate in Psoriasis Patients, Comorbidity Profiles and Risk Factor Analysis
  • Abstract Number: 1212
    Psychological Profile in Patients with Rheumatic Diseases in China: A Study of HADS Self-assessment with Smart System of Disease Management (SSDM)
  • Abstract Number: 1203
    Psychometric Properities of the Patient Related Outcome Measure FACIT-Fatigue in Rheumatic Arthritis and Psoriatic Arthritis: A Literature Review
  • Abstract Number: 431
    Psychometric Properties of the Pediatric Patient-Reported Outcomes Measurement Information System (PROMIS®) Item Banks in a Dutch Clinical Sample of Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 1461
    Pulmonary Cysts: Very Common Finding on Computed Tomography of the Chest of Asymptomatic Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 2006
    Pyruvate Kinase M2 May Contribute to the Inflammation and Joint Destruction in Rheumatoid Arthritis
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences